Update on World Health Organization HIV Drug Resistance Prevention and Assessment Strategy: 2004-2011

被引：46

作者：

Jordan, M. R. ^{[1
,2
]}

Bennett, D. E. ^{[3
]}

Wainberg, M. A.

Havlir, D. ^{[4
]}

Hammer, S. ^{[5
]}

Yang, C. ^{[3
]}

Morris, L. ^{[6
]}

Peeters, M. ^{[7
,8
]}

Wensing, A. M. ^{[9
]}

Parkin, N. ^{[10
]}

Nachega, J. B. ^{[11
,12
]}

Phillips, A. ^{[13
]}

De Luca, A. ^{[14
,15
]}

Geng, E. ^{[4
]}

Calmy, A. ^{[16
,20
]}

Raizes, E. ^{[3
]}

Sandstrom, P. ^{[17
]}

Archibald, C. P. ^{[17
]}

Perriens, J.

McClure, C. M.

Hong, S. Y. ^{[2
]}

McMahon, J. H. ^{[2
,18
]}

Dedes, N. ^{[19
]}

Sutherland, D. ^{[17
]}

Bertagnolio, S.

机构：

[1] World Hlth Org, Dept HIV, CH-1211 Geneva 27, Switzerland

[2] Tufts Univ, Sch Med, Boston, MA 02111 USA

[3] US Ctr Dis Control & Prevent, Atlanta, GA USA

[4] Univ Calif San Francisco, San Francisco, CA 94143 USA

[5] Columbia Univ, Med Ctr, New York, NY USA

[6] Natl Inst Communicable Dis, AIDS Virus Res Unit, Johannesburg, South Africa

[7] Inst Rech Dev, UMI 233 TransVIHMI, Montpellier, France

[8] Univ Montpellier I, F-34006 Montpellier, France

[9] Univ Med Ctr Utrecht, Utrecht, Netherlands

[10] Data First Consulting, Belmont, CA USA

[11] Univ Stellenbosch, Cape Town, South Africa

[12] Johns Hopkins Bloomberg, Sch Publ Hlth, Baltimore, MD USA

[13] UCL, London WC1E 6BT, England

[14] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, Rome, Italy

[15] Siena Univ Hosp, Div Infect Dis, Siena, Italy

[16] Univ Hosp Geneva, Geneva, Switzerland

[17] Publ Hlth Agcy Canada, Ottawa, ON, Canada

[18] Alfred Hosp, Melbourne, Vic, Australia

[19] Int Treatment Preparedness Coalit, Bangkok, Thailand

[20] Med Sans Frontiere Access Campaign, Geneva, Switzerland

来源：

CLINICAL INFECTIOUS DISEASES | 2012年 / 54卷

基金：

美国国家卫生研究院; 比尔及梅琳达.盖茨基金会;

关键词：

EARLY-WARNING INDICATORS; ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; GENERIC PROTOCOL; PREGNANT-WOMEN; SURVEILLANCE; INDIVIDUALS; ADHERENCE; CLINICS; PREDICTORS;

D O I：

10.1093/cid/cis206

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

引用

页码：S245 / S249

页数：5

共 19 条

[1] An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition
St-Jean, M.
Harrigan, P. R.
Sereda, P.
Montaner, J. S. G.
Lima, V. D.
HIV MEDICINE, 2017, 18 (05) : 342 - 353
[2] Progress of implementation of the World Health Organization strategy for HIV drug resistance control in Latin America and the Caribbean
Ravasi, Giovanni
Jack, Noreen
Gonzalez, Monica Alonso
Sued, Omar
Dolores Perez-Rosales, Maria
Gomez, Bertha
Vila, Marcelo
del Riego, Amalia
Ghidinelli, Massimo
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2011, 30 (06): : 657 - 662
[3] HIV Drug Resistance Early Warning Indicators in Namibia with Updated World Health Organization Guidance
Jonas, Anna
Sumbi, Victor
Mwinga, Samson
DeKlerk, Michael
Tjituka, Francina
Penney, Scott
Jordan, Michael R.
Desta, Tiruneh
Tang, Alice M.
Hong, Steven Y.
PLOS ONE, 2014, 9 (07):
[4] Assessment of the World Health Organization's HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia
Mutenda, Nicholus
Bukowski, Alexandra
Nitschke, Anne-Marie
Nakanyala, Tuli
Hamunime, Ndapewa
Mekonen, Tadesse
Tjituka, Francina
Mazibuko, Greatjoy
Mwinga, Samson
Mabirizi, David
Sagwa, Evans
Indongo, Rosalia
Dean, Natalie
Jordan, Michael R.
Hong, Steven Y.
PLOS ONE, 2016, 11 (12):
[5] HIV Drug Resistance Early Warning Indicators in Cohorts of Individuals Starting Antiretroviral Therapy Between 2004 and 2009: World Health Organization Global Report From 50 Countries
Bennett, Diane E.
Jordan, Michael R.
Bertagnolio, Silvia
Hong, Steven Y.
Ravasi, Giovanni
McMahon, James H.
Saadani, Ahmed
Kelley, Karen F.
CLINICAL INFECTIOUS DISEASES, 2012, 54 : S280 - S289
[6] World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
Falzon, Dennis
Schunemann, Holger J.
Harausz, Elizabeth
Gonzalez-Angulo, Lice
Lienhardt, Christian
Jaramillo, Ernesto
Weyer, Karin
EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (03)
[7] Monitoring HIV Drug Resistance Early Warning Indicators in Cameroon: A Study Following the Revised World Health Organization Recommendations
Fokam, Joseph
Elat, Jean-Bosco N.
Billong, Serge C.
Kembou, Etienne
Nkwescheu, Armand S.
Obam, Nicolas M.
Essiane, Andre
Torimiro, Judith N.
Ekanmian, Gatien K.
Ndjolo, Alexis
Shiro, Koulla S.
Bissek, Anne C. Z-K.
PLOS ONE, 2015, 10 (06):
[8] Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in "Real-World" Settings
Brenner, Bluma G.
Ibanescu, Ruxandra-Ilinca
Hardy, Isabelle
Roger, Michel
VIRUSES-BASEL, 2018, 10 (01):
[9] Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness
Glaubius, Robert
Ding, Yajun
Penrose, Kerri J.
Hood, Greg
Engquist, Erik
Mellors, John W.
Parikh, Urvi M.
Abbas, Ume L.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (05)
[10] Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe
Ciaranello, Andrea L.
Perez, Freddy
Engelsmann, Barbara
Walensky, Rochelle P.
Mushavi, Angela
Rusibamayila, Asinath
Keatinge, Jo
Park, Ji-Eun
Maruva, Matthews
Cerda, Rodrigo
Wood, Robin
Dabis, Francois
Freedberg, Kenneth A.
CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : 430 - 446

← 1 2 →